Dr. Leyi Wang
University of Illinois at Urbana-Champaign
Dr. Leyi Wang, Clinical Assistant Professor of Veterinary Clinical Medicine and Virology Section Head at the Veterinary Diagnostic Laboratory, College of Veterinary Medicine, University of Illinois at Urbana-Champaign; Board-Certified Veterinary Virologist with the American College of Veterinary Microbiologists. Dr. Wang has co-authored 66 peer-reviewed articles and 5 book chapters. He is a co-inventor on one US patent. Dr. Wang is a grant reviewer for the NIH and National Pork Board, Associate Editor for Medical Research & Publication, and Editorial Board member for Medicine, Scientific Reports, Journal of Veterinary Diagnostic Investigation, World Journal of Virology, and Journal of Clinical and Translational Hepatology. His significant contributions to the coronavirus field include the first reported identification of a variant of PEDV, porcine deltacoronavirus in diarrheic pigs, novel sparrow deltacoronavirus, new bottlenose dolphin coronavirus, SARS-CoV-2 in tigers, and a new variant PRCV. He has many years of experience in vaccine development and first described the application of the homodimeric property of proteins in the use of protein polymers as vaccine platforms. Since 2015, Dr. Wang has been using Next-Generation Sequencing technology for whole genome sequencing of pathogens, especially emerging agents.